Results
|
2001.
|
AEG-1 overexpression is essential for maintenance of malignant state in human AML cells via up-regulation of Akt1 mediated by AURKA activation. [electronic resource] by
- Long, Min
- Hao, Miaowang
- Dong, Ke
- Shen, Jianjun
- Wang, Xi
- Lin, Fang
- Liu, Li
- Wei, Junxia
- Liang, Yingmin
- Yang, Jian
- Gu, Fangna
- Zhang, Huizhong
Producer: 20131029
In:
Cellular signalling vol. 25
Availability: No items available.
|
|
2002.
|
|
|
2003.
|
|
|
2004.
|
|
|
2005.
|
|
|
2006.
|
Growth suppression and mitotic defect induced by JNJ-7706621, an inhibitor of cyclin-dependent kinases and aurora kinases. [electronic resource] by
- Matsuhashi, A
- Ohno, T
- Kimura, M
- Hara, A
- Saio, M
- Nagano, A
- Kawai, G
- Saitou, M
- Takigami, I
- Yamada, K
- Okano, Y
- Shimizu, K
Producer: 20121003
In:
Current cancer drug targets vol. 12
Availability: No items available.
|
|
2007.
|
Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer. [electronic resource] by
- Hu, Zhi
- Mao, Jian-Hua
- Curtis, Christina
- Huang, Ge
- Gu, Shenda
- Heiser, Laura
- Lenburg, Marc E
- Korkola, James E
- Bayani, Nora
- Samarajiwa, Shamith
- Seoane, Jose A
- Dane, Mark A
- Esch, Amanda
- Feiler, Heidi S
- Wang, Nicholas J
- Hardwicke, Mary Ann
- Laquerre, Sylvie
- Jackson, Jeff
- W Wood, Kenneth
- Weber, Barbara
- Spellman, Paul T
- Aparicio, Samuel
- Wooster, Richard
- Caldas, Carlos
- Gray, Joe W
Producer: 20180129
In:
Breast cancer research : BCR vol. 18
Availability: No items available.
|
|
2008.
|
|
|
2009.
|
AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disorders. [electronic resource] by
- Dawson, Mark A
- Curry, Jayne E
- Barber, Kelly
- Beer, Philip A
- Graham, Brent
- Lyons, John F
- Richardson, Caroline J
- Scott, Mike A
- Smyth, Tomoko
- Squires, Matthew S
- Thompson, Neil T
- Green, Anthony R
- Wallis, Nicola G
Producer: 20100901
In:
British journal of haematology vol. 150
Availability: No items available.
|
|
2010.
|
Initial testing of the aurora kinase A inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP). [electronic resource] by
- Maris, John M
- Morton, Christopher L
- Gorlick, Richard
- Kolb, E Anders
- Lock, Richard
- Carol, Hernan
- Keir, Stephen T
- Reynolds, C Patrick
- Kang, Min H
- Wu, Jianrong
- Smith, Malcolm A
- Houghton, Peter J
Producer: 20100624
In:
Pediatric blood & cancer vol. 55
Availability: No items available.
|
|
2011.
|
|
|
2012.
|
|
|
2013.
|
|
|
2014.
|
Gene network disruptions and neurogenesis defects in the adult Ts1Cje mouse model of Down syndrome. [electronic resource] by
- Hewitt, Chelsee A
- Ling, King-Hwa
- Merson, Tobias D
- Simpson, Ken M
- Ritchie, Matthew E
- King, Sarah L
- Pritchard, Melanie A
- Smyth, Gordon K
- Thomas, Tim
- Scott, Hamish S
- Voss, Anne K
Producer: 20101028
In:
PloS one vol. 5
Availability: No items available.
|
|
2015.
|
|
|
2016.
|
|
|
2017.
|
The aurora kinase inhibitor CCT137690 downregulates MYCN and sensitizes MYCN-amplified neuroblastoma in vivo. [electronic resource] by
- Faisal, Amir
- Vaughan, Lynsey
- Bavetsias, Vassilios
- Sun, Chongbo
- Atrash, Butrus
- Avery, Sian
- Jamin, Yann
- Robinson, Simon P
- Workman, Paul
- Blagg, Julian
- Raynaud, Florence I
- Eccles, Suzanne A
- Chesler, Louis
- Linardopoulos, Spiros
Producer: 20120315
In:
Molecular cancer therapeutics vol. 10
Availability: No items available.
|
|
2018.
|
Combining histone deacetylase inhibitor vorinostat with aurora kinase inhibitors enhances lymphoma cell killing with repression of c-Myc, hTERT, and microRNA levels. [electronic resource] by
- Kretzner, Leo
- Scuto, Anna
- Dino, Pamela M
- Kowolik, Claudia M
- Wu, Jun
- Ventura, Patrick
- Jove, Richard
- Forman, Stephen J
- Yen, Yun
- Kirschbaum, Mark H
Producer: 20110920
In:
Cancer research vol. 71
Availability: No items available.
|
|
2019.
|
Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells. [electronic resource] by
- Yuan, Chun-Xiu
- Zhou, Zhi-Wei
- Yang, Yin-Xue
- He, Zhi-Xu
- Zhang, Xueji
- Wang, Dong
- Yang, Tianxing
- Pan, Si-Yuan
- Chen, Xiao-Wu
- Zhou, Shu-Feng
Producer: 20160809
In:
Drug design, development and therapy vol. 9
Availability: No items available.
|
|
2020.
|
Differentially expressed epigenome modifiers, including aurora kinases A and B, in immune cells in rheumatoid arthritis in humans and mouse models. [electronic resource] by
- Glant, Tibor T
- Besenyei, Timea
- Kádár, András
- Kurkó, Júlia
- Tryniszewska, Beata
- Gál, János
- Soós, Györgyi
- Szekanecz, Zoltán
- Hoffmann, Gyula
- Block, Joel A
- Katz, Robert S
- Mikecz, Katalin
- Rauch, Tibor A
Producer: 20130904
In:
Arthritis and rheumatism vol. 65
Availability: No items available.
|